Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryuichi Morishita

Showing results (1-10 of 353) with videos related to

Pageof 36
Sort By:
Atherosclerosis. Supplements|November 9, 2005
A scientific rationale for the CREST trial results: evidence for the mechanism of action of cilostazol in restenosisRyuichi Morishita
Circulation Journal : Official Journal of the Japanese Circulation Society|December 25, 2002
Recent progress in gene therapy for cardiovascular diseaseRyuichi Morishita
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|November 12, 2002
[Gene therapy in cardiovascular medicine as new pharmacological therapy]Ryuichi Morishita
Journal of Pharmacological Sciences|May 22, 2004
Perspective in progress of cardiovascular gene therapyRyuichi Morishita
Clinical Calcium|May 3, 2011
[Hypertension, CKD and bone metabolism]Hironori Nakagami, Ryuichi Morishita
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 15, 2006
[Therapeutic angiogenesis for ischemic diseases]Motokuni Aoki, Ryuichi Morishita
Clinical Calcium|July 2, 2009
[Hormones and osteoporosis update. Effect of angiotensin II on bone metabolism]Hironori Nakagami, Ryuichi Morishita
Frontiers in Endocrinology|September 25, 2014
Brain alterations and clinical symptoms of dementia in diabetes: aβ/tau-dependent and independent mechanismsNaoyuki Sato, Ryuichi Morishita
Current Pharmaceutical Design|November 27, 2012
Gene polymorphism of angiotensin II type 1 and type 2 receptorsTomohiro Katsuya, Ryuichi Morishita
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 14, 2009
[Gene therapy for anti-aging medicine]Hironori Nakagami, Ryuichi Morishita
Pageof 36

Showing results (1-10 of 353) with videos related to

Sort By:
Pageof 36
Atherosclerosis. Supplements|November 9, 2005
A scientific rationale for the CREST trial results: evidence for the mechanism of action of cilostazol in restenosisRyuichi Morishita
Circulation Journal : Official Journal of the Japanese Circulation Society|December 25, 2002
Recent progress in gene therapy for cardiovascular diseaseRyuichi Morishita
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|November 12, 2002
[Gene therapy in cardiovascular medicine as new pharmacological therapy]Ryuichi Morishita
Journal of Pharmacological Sciences|May 22, 2004
Perspective in progress of cardiovascular gene therapyRyuichi Morishita
Clinical Calcium|May 3, 2011
[Hypertension, CKD and bone metabolism]Hironori Nakagami, Ryuichi Morishita
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 15, 2006
[Therapeutic angiogenesis for ischemic diseases]Motokuni Aoki, Ryuichi Morishita
Clinical Calcium|July 2, 2009
[Hormones and osteoporosis update. Effect of angiotensin II on bone metabolism]Hironori Nakagami, Ryuichi Morishita
Frontiers in Endocrinology|September 25, 2014
Brain alterations and clinical symptoms of dementia in diabetes: aβ/tau-dependent and independent mechanismsNaoyuki Sato, Ryuichi Morishita
Current Pharmaceutical Design|November 27, 2012
Gene polymorphism of angiotensin II type 1 and type 2 receptorsTomohiro Katsuya, Ryuichi Morishita
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 14, 2009
[Gene therapy for anti-aging medicine]Hironori Nakagami, Ryuichi Morishita
Pageof 36